These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 848532)

  • 1. The abortifacient and oxytocic effects of an intravaginal silicone rubber device containing a 0.5% concentration of 15(S)-15-methyl-prostaglandin F2alpha methyl ester.
    Lauersen NH; Wilson KH
    Am J Obstet Gynecol; 1977 Apr; 127(7):784-7. PubMed ID: 848532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of a 10 cm2, 0.5% 15-ME-PGF2alpha methyl ester intravaginal silastic device on abortion and plasma prostaglandin concentration.
    Lauersen NH; Wilson KH
    Prostaglandins; 1977 Apr; 13(4):755-62. PubMed ID: 857275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormone release and abortifacient effectiveness of a newly developed silastic device containing 15-ME-PGF2alpha methyl ester in concentrations of 0.5% and 1.0%.
    Lauersen NH; Wilson KH
    Prostaglandins; 1976; 12 Suppl():63-79. PubMed ID: 968066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Midtrimester abortion induced by single intra-amniotic instillation of two dose schedules of 15(S)-15-methyl-prostaglandin F2alpha.
    Lauersen NH; Wilson KH
    Prostaglandins; 1975 Apr; 9(4):617-25. PubMed ID: 1153812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The abortifacient effectiveness and plasma prostaglandin concentrations with 15(S)-15-methyl prostaglandin F2alpha methyl ester-containing vaginal silastic devices.
    Lauersen NH; Wilson KH
    Fertil Steril; 1976 Dec; 27(12):1366-73. PubMed ID: 1001521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The abortifacient effects of a newly developed vaginal silastic device impregnated with an 0.5% concentration of 15(S)-15-methyl-prostaglandin F2alpha methyl ester in the first trimester.
    Lauersen NH; Wilson KH
    Contraception; 1976 Jun; 13(6):697-705. PubMed ID: 1277841
    [No Abstract]   [Full Text] [Related]  

  • 7. The efficacy of intravaginal 15 methyl prostaglandin F2alpha methyl ester in first and second trimester abortion.
    Dillon TF; Mootabar H; Phillips LL; Risk A
    Prostaglandins; 1976; 12 Suppl():81-98. PubMed ID: 968067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical observations with a prostaglandin-containing silastic vaginal device for pregnancy termination.
    Hendricks CH; Dingfelder JR; Gruber WS
    Prostaglandins; 1976; 12 Suppl():99-122. PubMed ID: 968068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Second trimester abortion: single dose intra-amniotic injection of prostaglandin F2alpha with intravenous oxytocin augmentation.
    Perry G; Siegal B; Held B
    Prostaglandins; 1977 May; 13(5):987-94. PubMed ID: 866706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of vaginal delivery systems containing 15[s]15-methyl PGF2alpha methyl ester.
    Spilman CH; Beuving DC; Forbes AD; Roseman TJ; Larion LJ
    Prostaglandins; 1976; 12 Suppl():1-16. PubMed ID: 968060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interruption of pregnancy by prostaglandin 15-methyl F2alpha.
    Bolognese RJ; Corson SL
    Fertil Steril; 1975 Jul; 26(7):695-9. PubMed ID: 1149900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intra-amniotic administration of 15(S)-15-methyl-prostaglandin F2alpha for the induction of midtrimester abortion.
    Dingfelder JR; Black J; Brenner WE; Staurovsky LG; Gruber W
    Am J Obstet Gynecol; 1976 Jul; 125(6):821-6. PubMed ID: 937408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Termination of midtrimester pregnancy by serial intramuscular injections of 15(S)-15-methyl-prostaglandin F2alpha.
    Lauersen NH; Wilson KH
    Am J Obstet Gynecol; 1976 Jan; 124(2):169-76. PubMed ID: 1247053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early first-trimester abortion induction by Silastic vaginal devices for continuous release of 15(S)=15-methyl prostaglandin F2alpha methyl ester.
    Robins J
    Fertil Steril; 1977 Oct; 28(10):1048-55. PubMed ID: 561712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fertility control--symposium on prostaglandins: comment.
    Brenner WE
    Fertil Steril; 1976 Dec; 27(12):1380-6. PubMed ID: 1001523
    [No Abstract]   [Full Text] [Related]  

  • 16. Prostaglandin F2 alpha, oxytocin, and uterine activation in hypertonic saline-induced abortions.
    Fuchs AR; Rasmussen AB; Rehnström J; Toth M
    Am J Obstet Gynecol; 1984 Sep; 150(1):27-32. PubMed ID: 6476024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of abortion by vaginal administration of 15(s)15-methyl prostaglandin F2alpha methyl ester. A comparison of two delivery systems.
    Bygdeman M; Gréen K; Lundström V; Ramadan M; Fotiou S; Bergström S
    Prostaglandins; 1976; 12 Suppl():27-51. PubMed ID: 968064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 15 (S)-15-methyl-prostaglandin F2alpha: myometrial response and abortifacient efficacy.
    Wiqvist N; Béguin F; Bygdeman M; Toppozada M
    Adv Biosci; 1973; 9():831-42. PubMed ID: 4805896
    [No Abstract]   [Full Text] [Related]  

  • 19. Induction of midtrimester abortion by serial intravaginal administration of 15(S)-15-methyl-prostaglandin F2alpha (THAM) suppositories.
    Lauersen NH; Wilson KH
    Prostaglandins; 1975 Dec; 10(6):1037-45. PubMed ID: 1208882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostaglandins and abortion. III. Comparison of single intra-amniotic injections of 15-methyl prostaglandin F2alpha and prostaglandin F2alpha for termination of second-trimester pregnancy: an international multicenter study. World Health Organization Tast Force on the Use of Prostaglandins forthe Regulation of Fertility.
    Am J Obstet Gynecol; 1977 Nov; 129(6):601-6. PubMed ID: 920761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.